Sofosbuvir (direct-acting antiviral drug that inhibits the replication of the HCV virus by targeting a specific protein necessary for viral replication).
Velpatasvir (direct-acting antiviral that blocks the action of another protein involved in the HCV replication process).
Therapeutic effects:
Reduction of liver inflammation and fibrosis caused by HCV infection.
Eradication of the virus, which reduces the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma.
Important information:
Do not take if you have a known allergy or hypersensitivity to Velpaclear or any of its components.
Not recommended for children under 18 years of age.
Consult a doctor before use if you have any chronic diseases or take other medications.
How to consume:
Read the instructions carefully before taking.
Take as directed by your doctor.
Can be taken with or without food.
If you experience side effects, stop taking and consult your doctor.
Storage:
Store at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
Keep away from moisture, heat, and light.
Do not freeze.
Keep away from children and pets.
Safety advices:
Pregnancy: Limited information about the safety of Velpaclear in pregnancy. Consult a doctor about the risks and benefits.
Breastfeeding: Limited information about the safety of Velpaclear in breastfeeding. Consult a doctor about the risks and benefits.
Chronic lung disease: If you have a chronic lung disease, talk to your doctor about the risks and benefits.
Liver disease: If you have liver disease, talk to your doctor about the risks and benefits.
Alcohol: Avoid alcohol consumption during hepatitis C treatment.
Driving: If you experience side effects such as headache, fatigue, or dizziness, refrain from driving or operating heavy machinery.
Side effects:
Serious: Hepatitis B reactivation, severe allergic reactions.
Can Velpaclear tablet cure hepatitis C in individuals with advanced liver disease or cirrhosis?
Velpaclear tablet has shown efficacy in treating hepatitis C in individuals with advanced liver disease or compensated cirrhosis. However, the response rate may vary, and close monitoring of liver function is important during and after treatment.
Is it necessary to undergo regular blood tests while on Velpaclear tablet treatment?
Yes, regular blood tests are typically conducted during Velpaclear tablet treatment to monitor liver function, viral load, and treatment response.
Can Velpaclear tablet be used in patients with kidney disease?
Velpaclear tablet can be used in patients with mild to moderate kidney impairment without dose adjustment. However, patients with severe renal impairment or end-stage renal disease may require dose adjustments or alternative treatment options.
Can Velpaclear tablet be used in patients with HIV co-infection?
Velpaclear tablet is effective and safe in individuals with both hepatitis C and HIV co-infection. However, it is important to coordinate treatment with both infectious disease and HIV specialists.
Can Velpaclear tablet cause weight gain or loss?
Weight gain or loss is not commonly reported as a side effect of the Velpaclear tablet. However, individual responses to medication can vary.
Can Velpaclear tablet be used in patients with a history of liver transplantation?
Velpaclear tablet can be used in patients with a history of liver transplantation who have recurrent hepatitis C. However, individual patient factors and the specific post-transplantation period must be considered.
Can Velpaclear tablet cause any serious side effects?
While Velpaclear tablet is generally well-tolerated, like any medication, it can potentially cause side effects. Serious side effects are rare but can include severe allergic reactions, changes in heart rate, and liver problems.